Home › Funds › Eversept Partners, LP › VKTX

Eversept Partners, LP position in VKTX

VIKING THERAPEUTICS INC · Health Care

Eversept Partners, LP reported holding 602,922 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$23.5M, representing 1.23% of its reported portfolio and ranking #22 among its reported holdings. Eversept Partners, LP has disclosed VKTX holdings in 4 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)602.92K sh
Reported value held$23.52M
Portfolio Weight1.23%
First reportedQ1 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Eversept Partners, LP's VKTX position evolved

Eversept Partners, LP first disclosed a stake in VKTX in Q1 2024 at 22,818 shares (US$1.9M). The position peaked in Q2 2026 at 602,922 shares, worth US$23.5M. Across 4 filings, Eversept Partners, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 602,922 shares valued at US$23.5M — an increase of 363,812 shares quarter over quarter.. Notable position changes include a 507% increase in Q2 2024 (shares rose 19% over the following quarter), a 152% increase in Q2 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 22.82K $1.87M New
Q2 2024 138.49K $7.34M Add
Q1 2026 239.11K $7.78M New
Q2 2026 602.92K $23.52M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 34 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), ADAR1 Capital Management, LLC (US$22.4M), TANG CAPITAL MANAGEMENT LLC (US$19.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has Eversept Partners, LP held VKTX?

Eversept Partners, LP has disclosed VKTX holdings in 4 of the last 10 reported quarters, going back to Q1 2024.

What is Eversept Partners, LP's current position in VKTX?

As of Q2 2026, Eversept Partners, LP holds 602.92K shares of VKTX (VIKING THERAPEUTICS INC), valued at $23.52M, representing 1.23% of its reported portfolio and ranking #22.

Has Eversept Partners, LP been buying or selling VKTX?

In the latest 13F filing (Q2 2026), Eversept Partners, LP increased its position in VKTX. The position peaked in Q2 2026 at 602.92K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Vestal Point Capital, LP, ADAR1 Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.